Table 2 In-hospital mortality related to groups, CP titers and days from symptom onset
From: Convalescent plasma treatment for patients of 80 years and older with COVID-19 pneumonia
Sample Size, n | Mortality, n (%) | p-value | |
|---|---|---|---|
Control group | 82 | 22 (26.8) | 0.128 |
Convalescent Plasma group | 41 | 6 (14.6) | |
Low-titer CP | 20 | 4 (20.0) | 0.307 |
High-titer CP | 21 | 2 (9.5) | |
Symptom onset to CP < 7 days | 20 | 2 (10.0) | 0.355 |
Symptom onset to CP ≥ 7 days | 21 | 4 (19.1) |